✦ LIBER ✦

Short duration combination chemotherapy in the treatment of small cell lung cancer (S.C.L.C.)

Book ID: 122009479
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 179 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80460-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short duration combination chemotherapy

Short duration combination chemotherapy in the treatment of small cell lung cancer

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Combined modality treatment of short dur

Combined modality treatment of short duration in small cell lung cancer

✍ Bakker, W; Nijhuis-Heddes, J.M.A; Van Oosterom, A.T; Noordijk, E.M; Hermans, J; 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 581 KB

Chemotherapy of small-cell lung cancer:

Chemotherapy of small-cell lung cancer: duration of treatment

✍ Splinter, T.A.W. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Mitomycin C, vinblastine and cisplatin c

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer

✍ Fumio Nomura; Kaoru Shimokata; Hiroshi Saito; Shuzo Sakai; Atsushi Watanabe; Hid 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 277 KB

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Mitomycin C, vinblastine and cisplatin c

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 323 KB